University of California San Francisco

Norah Terrault - 144
Norah
Terrault
MD, MPH

Professor of Clinical Medicine & Surgery
Departments of Medicine & Surgery
Director of Viral Hepatitis Research in Liver Transplantation

Address

513 Parnassus Avenue, MSB, #001
San Francisco, CA 94143
United States

Email: [email protected]
Phone: 415-476-2227
Fax: 415-476-0659

ORCID: 0000-0003-4143-1950

Biography

Dr. Norah Terrault is a hepatologist or liver specialist who is recognized internationally for the treatment of viral hepatitis and liver transplantation. Her research includes the study of viral hepatitis and its progression and treatment, especially in liver transplant patients. Her research includes several clinical trials related to preventing and treating chronic hepatitis C and B. Her studies in this area have been presented to the American Association for the Study of Liver Diseases, the leading organization for research in liver disease.

Terrault completed medical training at the University of Alberta and specialty medical training in Internal Medicine and Gastroenterology at the University of Toronto, both in Canada. Her post-doctoral fellowship in hepatology and viral hepatitis was completed at the University of California, San Francisco while earning a concurrent master's degree in public health from the University of California at Berkeley. She joined the medical staff at UCSF Medical Center in 1997.

Education

Institution Degree Dept or School End Date
University of California, San Francisco Post-Doc Fellow/Scholar Medicine 1995
University of Alberta M.D. School of Medicine 1987
University of California, San Francisco Residency
University of California, San Francisco Clinical Fellowship Gastroenterology

Board Certifications

American Board of Internal Medicine, Internal Medicine

American Board of Internal Medicine, Gastroenterology

Clinical Expertise

Alcoholic Liver Disease
Autoimmune Hepatitis
Benign Liver Tumors
Cirrhosis
Fulminant Hepatic Failure
Hepatitis B
Hepatitis C
Hepatocellular Carcinoma (Liver Cancer)
Live Donor Liver Transplantation
Liver Transplantation
Nonalcoholic Fatty Liver Disease
Pancreas Transplantation
Primary Biliary Cirrhosis
Primary Sclerosing Cholangitis

Clinical Trials

  1. Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. (NCT01804829)
    Related Conditions: Hepatitis C, Viruses, Hepatocellular Cancer, Liver Cancer, Hepatitis, Cirrhosis, Liver Transplant, Hepatitis A| Start Date: | End Date:
  2. Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation (NCT01421212)
    Related Conditions: Hepatitis B, Liver Disease, Liver Transplant, Hepatitis A, Hepatitis| Start Date: | End Date:

Program Affiliations

UCSF Liver Center

In the News

New AASLD Video Showcases UCSF Liver Transplant Program
December, 20, 2014 | UCSF Transplant Surgery

Grants and Funding

  • USC Cirrhosis Clinical Center | NIH | 2021-09-22 - 2026-08-31 | Role: Principal Investigator
  • Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) | NIH | 2002-06-15 - 2024-06-30 | Role: Principal Investigator
  • Hepatitis B Research Network (HBRN): Natural History and Treatment Studies | NIH | 2008-09-30 - 2021-05-31 | Role: Principal Investigator
  • Bay Area Hepatitis C Cooperative Research Center | NIH | 2010-06-15 - 2016-05-31 | Role: Co-Investigator
  • General Clinical Research Center | NIH | 1974-12-01 - 2009-03-31 | Role: Co-Investigator
  • Resistance to Antiviral Therapy in Chronic Hepatitis C | NIH | 2001-08-01 - 2007-04-30 | Role: Principal Investigator

Research Narrative

My research focuses on the natural history and treatment of hepatitis C virus (HCV) and hepatitis B virus (HBV), particularly in special populations, including those undergoing liver transplantation. Work in progress addresses the natural history of post-transplant disease and specific therapies to prevent infection or modify HCV and HBV disease progression and loss of grafts from recurrent disease.

Our virological analyses are focused on characterization of viral mutations that occur in liver transplant recipients receiving antiviral therapies and assessment of the effect of these variant viruses on the natural history and severity of disease post-transplantation. Knowledge of these factors may allow improved organ allocation by identifying subsets of patients with HCV recurrence in liver grafts who would be favorable or unfavorable candidates for retransplantation. 

Research Interests

Liver Injury and Repair

Hepatitis B virus (HBV)

Hepatitis C virus (HCV)

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 421
  1. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success.
    MĂ©ndez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, Shen H, Manos MM, Lanier LL, Ryan JC, McCune JM, Hartigan-O'Connor DJ| | PubMed
  2. Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.
    VanWagner LB, Khan SS, Ning H, Siddique J, Lewis CE, Carr JJ, Vos MB, Speliotes E, Terrault NA, Rinella ME, Lloyd-Jones DM, Allen NB| | PubMed
  3. Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.
    Saxena V, Khungar V, Verna EC, Levitsky J, Brown RS, Hassan MA, Sulkowski MS, O'Leary JG, Koraishy F, Galati JS, Kuo AA, Vainorius M, Akushevich L, Nelson DR, Fried MW, Terrault N, Reddy KR| | PubMed
  4. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA| | PubMed
  5. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault NA, Siddique J| | PubMed
  6. Management of hepatitis B in special populations.
    Zhou K, Terrault N| | PubMed
  7. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Terrault NA, McCaughan GW, Curry MP, Gane E, Fagiuoli S, Fung JYY, Agarwal K, Lilly L, Strasser SI, Brown KA, Gadano A, Kwo PY, Burra P, Samuel D, Charlton M, Pessoa MG, Berenguer M| | PubMed
  8. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Terrault NA, Berenguer M, Strasser SI, Gadano A, Lilly L, Samuel D, Kwo PY, Agarwal K, Curry MP, Fagiuoli S, Fung JYY, Gane E, Brown KA, Burra P, Charlton M, Pessoa MG, McCaughan GW| | PubMed
  9. Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.
    Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, MĂĽllhaupt B| | PubMed
  10. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Ajmera VH, Terrault NA, Harrison SA| | PubMed
421
View all 421 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 421
  1. Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue Withdrawal.
    Terrault NA, Sterling R, Lok AS, Ghany MG, Feld JJ, Cloherty G, Wahed AS, Yang X| | PubMed
  2. HBV-specific T-cell function is nonenhanced by tenofovir-induced decline in HBV viremia or HBsAg titer in chronic hepatitis B.
    Traum D, Wong DK, Lau DT, Sterling RK, Terrault NA, Khalili M, Wahed AS, Lee WM, Block TM, Lok ASF, Chang KM, Hepatitis B Research Network (HBRN)| | PubMed
  3. Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign-Born: The FOCUS-HBV Multicentre Cohort.
    Zhou K, Lee A, Wong C, Rangnekar AS, Chen A, Ajokubi J, Keller AI, Smith CI, Hitawala AA, Mironova M, Gopalakrishna H, Norman-Wheeler J, Ghany MG, Dodge JL, Terrault NA, Hsu CC| | PubMed
  4. Erratum: HDV RNA assays: Performance characteristics, clinical utility, and challenges.
    Wedemeyer H, Leus M, Battersby TR, Glenn J, Gordien E, Kamili S, Kapoor H, Kessler HH, Lenz O, LĂĽtgehetmann M, Mixson-Hayden T, Simon CO, Thomson M, Westman G, Miller V, Terrault N, Lampertico P, HDV RNA Assays Writing Group at the HBV Forum| | PubMed
  5. Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder.
    Meinders AM, Connor AA, Ontiveros J, Elaileh A, Patel K, Todd J, Nottage DL, Brombosz EW, Moore LW, Simon CJ, Cheah YL, Hobeika MJ, Mobley CM, Saharia A, Basra T, Kodali S, Victor DW, Lee BP, Terrault N, Li XC, Gaber AO, Ghobrial RM| | PubMed
  6. Longer travel and traffic are associated with adult liver transplant waitlist mortality in the United States.
    Zhou K, Albertian R, Wong C, Kuo LS, Thompson LK, Dodge JL, Mehta N, Terrault NA, Cockburn MG| | PubMed
  7. Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.
    Danpanichkul P, Duangsonk K, Chen VL, Saokhieo P, Dejvajara D, Sukphutanan B, Aboona MB, Lopimpisuth C, Pang Y, Ibrahim AF, Fallon MB, Huang DQ, Kim D, Singal AG, Yang JD, Aqel BA, Terrault NA, Wijarnpreecha K| | PubMed
  8. Quest for HBV functional cure: what have we learnt from silencing RNAs?
    Terrault N, Lok AS| | PubMed
  9. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies.
    Polaris Observatory Collaborators. Electronic address: [email protected], Polaris Observatory Collaborators| | PubMed
  10. Association of Alcohol and Incremental Cardiometabolic Risk Factors With Liver Disease: A National Cross-sectional Study.
    Lee BP, Molina J, Kim S, Dodge JL, Terrault NA| | PubMed
  11. Antivirals in Preventing Perinatal Transmission of Hepatitis B: Start and Stop Times are Shifting.
    Terrault NA, Vargas HE| | PubMed
  12. Epidemiology and Outcomes of Alcohol-Associated Hepatitis in Adolescents and Young Adults.
    Flemming JA, Djerboua M, Chapman O, Ayonrinde O, Terrault NA| | PubMed
  13. Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.
    Arab JP, Díaz LA, Rehm J, Im G, Arrese M, Kamath PS, Lucey MR, Mellinger J, Thiele M, Thursz M, Bataller R, Burton R, Chokshi S, Francque SM, Krag A, Lackner C, Lee BP, Liangpunsakul S, MacClain C, Mandrekar P, Mitchell MC, Morgan MY, Morgan TR, Pose E, Shah VH, Shawcross D, Sheron N, Singal AK, Stefanescu H, Terrault N, Trépo E, Moreno C, Louvet A, Mathurin P| | PubMed
  14. Trends in Alcohol Use After the COVID-19 Pandemic: A National Cross-Sectional Study.
    Ayyala-Somayajula D, Dodge JL, Leventhal AM, Terrault NA, Lee BP| | PubMed
  15. The University of Southern California psychosocial checklist: A novel tool to remotely screen transplant candidates with alcohol-associated liver disease prior to hospital transfer.
    Edwards B, Ramirez S, Pappas J, Dodge JL, Han H, Kahn J, Ahearn A, Terrault NA, Lee BP| | PubMed
  16. Safety of acamprosate for alcohol use disorder after liver transplant: A pilot randomized controlled trial.
    Ayyala-Somayajula D, Bottyan T, Shaikh S, Lee BP, Cho SH, Dodge JL, Terrault NA, Han H| | PubMed
  17. Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study.
    Huang DQ, Wilson LA, Behling C, Amangurbanova M, Kleiner DE, Kowdley KV, Dasarathy S, Terrault NA, Diehl AM, Chalasani N, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J, Loomba R, NASH Clinical Research Network| | PubMed
  18. The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.
    Tapper EB, Goldberg D, Parikh ND, Terrault NA, Welch N, Sharpton S, Hameed B, Khalili M, Stolz A, Verna EC, Brown RS, Sanyal AJ, VanWagner L, Ladner DP, Moylan CA, Diehl AM, Jones PD, Loomba R, Dasarathy S, Simonetto DA, Shah VH, Bajaj JS, LCN Study Group| | PubMed
  19. Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
    Vinaixa C, DiMaira T, Russo FP, Goldberg D, Mazzola A, Walabh P, Price J, Sagal S, Kirchner V, Shaker T, Krag A, Pruett T, Coilly A, Terrault N, Berenguer M| | PubMed
  20. The Survival Benefit of Reabstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multicenter ACCELERATE Study.
    Dukewich M, Dodge JL, Lucey MR, Rice JP, Shetty K, Jakhete N, Im GY, Weinberg EM, Hsu C, Smith C, Ghobrial RM, Therapondos G, Shoreibah M, Aryan M, Eswaran S, Fix OK, Maddur H, Terrault N, Lee BP| | PubMed
  21. The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications.
    Ayyala-Somayajula D, Dodge JL, Zhou K, Terrault NA, Yuan L| | PubMed
  22. Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index.
    Zhou K, Lit A, Kuo LS, Thompson LK, Dodge JL, Mehta N, Terrault NA, Ha NB, Cockburn MG| | PubMed
  23. Liver transplantation for alcohol-associated liver disease.
    Simonetto DA, Winder GS, Connor AA, Terrault NA| | PubMed
  24. Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB.
    Ghany MG, King WC, Hinerman AS, Lok ASF, Lisker-Melman M, Chung RT, Terrault N, Janssen HLA, Khalili M, Lee WM, Lau DTY, Cloherty GA, Sterling RK| | PubMed
  25. Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement.
    Lee BP, Witkiewitz K, Mellinger J, Anania FA, Bataller R, Cotter TG, Curtis B, Dasarathy S, DeMartini KS, Diamond I, Diazgranados N, DiMartini AF, Falk DE, Fernandez AC, German MN, Kamath PS, Kidwell KM, Leggio L, Litten R, Louvet A, Lucey MR, McCaul ME, Sanyal AJ, Singal AK, Sussman NL, Terrault NA, Thursz MR, Verna EC, Radaeva S, Nagy LE, Mitchell MC| | PubMed
  26. Treatment of Hepatitis D - A Future Role for Combination Therapy.
    Terrault N| | PubMed
  27. The obstacle is the way: Finding a path to hepatitis C elimination.
    Lo Re V, Price JC, Schmitt S, Terrault N, Bhattacharya D, Aronsohn A| | PubMed
  28. Down-Classification of Hepatitis C Virus Diagnostics: Implications for Screening and Diagnosis.
    Terrault N| | PubMed
  29. PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease.
    Chalasani N, Vilar-Gomez E, Loomba R, Yates KP, Diehl AM, Neuschwander-Tetri BA, Dasarathy S, Kowdley KV, Terrault N, Wilson LA, Tonascia J, Sanyal AJ| | PubMed
  30. Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes.
    Peters MG, Yuen MF, Terrault N, Fry J, Lampertico P, Gane E, Hwang C, Stamm LM, Leus M, Maini MK, Mendez P, Lonjon-Domanec I, Berg T, Wang S, Mishra P, Donaldson E, Buchholz S, Miller V, Lenz O| | PubMed
  31. Maternal neighbourhood-level social determinants of health and their association with paediatric hepatitis C screening among children exposed to hepatitis C in pregnancy.
    Foley MK, Djerboua M, Kushner T, Biondi MJ, Feld JJ, Terrault NA, Flemming JA| | PubMed
  32. Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease.
    Rinella ME, Castro Narro GE, Krag A, Terrault N, Newsome PN| | PubMed
  33. Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †.
    Rinella ME, Castro Narro GE, Krag A, Terrault N, Newsome PN| | PubMed
  34. Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols.
    Xu M, Mayemura CT, Kong N, Genyk YS, Kahn JA, Terrault NA| | PubMed
  35. Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature.
    Lazarus JV, Newsome PN, Francque SM, Kanwal F, Terrault NA, Rinella ME| | PubMed
  36. Peginterferon as Part of a Functional Cure Strategy for Hepatitis B: Is the Juice Worth the Squeeze?
    Zhang TP, Terrault NA| | PubMed
  37. Reply: Recognizing the new nomenclature requires a comprehensive analysis of the prevalence, severity, and long-term outlook for SLD and subclassifications.
    Lee BP, Dodge JL, Terrault NA| | PubMed
  38. Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study.
    Aleyadeh W, Verna EC, Elbeshbeshy H, Sulkowski MS, Smith C, Darling J, Sterling RK, Muir A, Akushevich L, La D, Terrault N, Fried MW, Feld JJ| | PubMed
  39. Hepatitis C.
    Martinello M, Solomon SS, Terrault NA, Dore GJ| | PubMed
  40. National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature.
    Lee BP, Dodge JL, Terrault NA| | PubMed
  41. Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women.
    Maldonado SS, Cedars MI, Yates KP, Wilson LA, Gill R, Terrault NA, Suzuki A, Sarkar MA| | PubMed
  42. Reply: NAFLD, MAFLD, or MASLD? Cut the Gordian knot with "Ludwig disease".
    Newsome P, Rinella ME, Lazarus JV, Terrault N| | PubMed
  43. HDV RNA assays: Performance characteristics, clinical utility, and challenges.
    Wedemeyer H, Leus M, Battersby TR, Glenn J, Gordien E, Kamili S, Kapoor H, Kessler HH, Lenz O, LĂĽtgehetmann M, Mixson-Hayden T, Simon CO, Thomson M, Westman G, Miller V, Terrault N, Lampertico P, HDV RNA Assays Writing Group at the HBV Forum| | PubMed
  44. A global action agenda for turning the tide on fatty liver disease.
    Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Anstee QM, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Gastaldelli A, Hagström H, Huang TTK, Ivancovsky Wajcman D, Kautz A, Kopka CJ, Krag A, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Terrault NA, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM, Healthy Livers, Healthy Lives Collaborators| | PubMed
  45. Association of nativity with survival among adults with hepatocellular carcinoma.
    Zhou K, Song Z, Rostomian N, Dodge JL, Stern MC, Setiawan VW, Terrault NA, Cockburn MG, Liu L| | PubMed
  46. Global importance of new treatment strategies to efforts to control hepatitis B virus.
    Forbes C, Lavoie L, Satram S, Shen L, Thanawala V, Arizpe A, Terrault N| | PubMed
  47. Association of Alanine Aminotransferase Flares to Hepatitis B Surface Decline During Tenofovir Alone or With Pegylated Interferon Alfa.
    Perrillo R, Lok AS, Leonard K, Ghany MG, Terrault N, Belle SH, Janssen HLA, Hepatitis B Research Network| | PubMed
  48. Reply: People living with HIV and NAFLD and updated guidance on NAFLD screening.
    Rinella ME, Terrault N, Neuschwander-Tetri B, Loomba R| | PubMed
  49. Reply: ELF in the risk stratification of NAFLD-Are the ELF thresholds suggested by the AASLD guidelines appropriate?
    Rinella ME, Terrault N, Neuschwander-Tetri B, Loomba R, Abdelmalek M| | PubMed
  50. National Trends in Alcohol Use, Metabolic Syndrome, and Liver Disease From 1999 to 2018.
    Lee BP, Dodge JL, Mack WJ, Leventhal AM, Terrault NA| | PubMed
  51. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
    Huang DQ, Wilson LA, Behling C, Kleiner DE, Kowdley KV, Dasarathy S, Amangurbanova M, Terrault NA, Diehl AM, Chalasani N, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J, NASH Clinical Research Network, Loomba R| | PubMed
  52. Liver Transplantation 2023: Status Report, Current and Future Challenges.
    Terrault NA, Francoz C, Berenguer M, Charlton M, Heimbach J| | PubMed
  53. Use of HBV RNA and to predict change in serological status and disease activity in CHB.
    Ghany MG, King WC, Hinerman AS, Lok AS, Lisker-Melman M, Chung RT, Terrault N, Janssen HLA, Khalili M, Lee WM, Lau DTY, Cloherty GA, Sterling RK| | PubMed
  54. Population-attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi-ethnic cohort.
    Zhou K, Lim T, Dodge JL, Terrault NA, Wilkens LR, Setiawan VW| | PubMed
  55. Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals.
    Kushner T, Lange M, Argiriadi PA, Meislin R, Sigel K, Terrault N, Fatty Liver In Pregnancy (FLIP) Study Group| | PubMed
  56. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
    Razavi HA, Buti M, Terrault NA, Zeuzem S, Yurdaydin C, Tanaka J, Aghemo A, Akarca US, Al Masri NM, Alalwan AM, Aleman S, Alghamdi AS, Alghamdi S, Al-Hamoudi WK, Aljumah AA, Altraif IH, Asselah T, Ben-Ari Z, Berg T, Biondi MJ, Blach S, Braga WSM, Brandão-Mello CE, Brunetto MR, Cabezas J, Cheinquer H, Chen PJ, Cheon ME, Chuang WL, Coffin CS, Coppola N, Craxi A, Crespo J, De Ledinghen V, Duberg AS, Etzion O, Ferraz MLG, Ferreira PRA, Forns X, Foster GR, Gaeta GB, Gamkrelidze I, García-Samaniego J, Gheorghe LS, Gholam PM, Gish RG, Glenn J, Hercun J, Hsu YC, Hu CC, Huang JF, Janjua N, Jia J, Kåberg M, Kaita KDE, Kamal H, Kao JH, Kondili LA, Lagging M, Lázaro P, Lazarus JV, Lee MH, Lim YS, Marotta PJ, Navas MC, Naveira MCM, Orrego M, Osiowy C, Pan CQ, Pessoa MG, Raimondo G, Ramji A, Razavi-Shearer DM, Razavi-Shearer K, Ríos-Hincapié CY, Rodríguez M, Rosenberg WMC, Roulot DM, Ryder SD, Safadi R, Sanai FM, Santantonio TA, Sarrazin C, Shouval D, Tacke F, Tergast TL, Villalobos-Salcedo JM, Voeller AS, Yang HI, Yu ML, Zuckerman E, Polaris Observatory| | PubMed
  57. Healthcare affordability and effects on mortality among adults with liver disease from 2004 to 2018 in the United States.
    Ayyala-Somayajula D, Dodge JL, Farias A, Terrault N, Lee BP| | PubMed
  58. Global epidemiology of cirrhosis - aetiology, trends and predictions.
    Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, Loomba R| | PubMed
  59. Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO-PLUS study.
    Terrault NA, Slepin J, Kanner R, Gailloux K, Catalli L, McKinney J, Straley S, Morris P, Hluhanich R, Gonzalez-Flores A, Dodge J, Sarkar S| | PubMed
  60. Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis.
    Hsu CC, Dodge JL, Weinberg E, Im G, Ko J, Davis W, Rutledge S, Dukewich M, Shoreibah M, Aryan M, Vosooghi A, Lucey M, Rice J, Terrault NA, Lee BP| | PubMed
  61. Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial.
    Feld JJ, Wahed AS, Fried M, Ghany MG, Di Bisceglie AM, Perrillo RP, Khalili M, Yang X, Belle SH, Janssen HLA, Terrault N, Lok AS, Hepatitis B Research Network (HBRN)| | PubMed
  62. Addressing sex-based disparities in solid organ transplantation in the United States - a conference report.
    Sawinski D, Lai JC, Pinney S, Gray AL, Jackson AM, Stewart D, Levine DJ, Locke JE, Pomposelli JJ, Hartwig MG, Hall SA, Dadhania DM, Cogswell R, Perez RV, Schold JD, Turgeon NA, Kobashigawa J, Kukreja J, Magee JC, Friedewald J, Gill JS, Loor G, Heimbach JK, Verna EC, Walsh MN, Terrault N, Testa G, Diamond JM, Reese PP, Brown K, Orloff S, Farr MA, Olthoff KM, Siegler M, Ascher N, Feng S, Kaplan B, Pomfret E| | PubMed
  63. The scientific basis of combination therapy for chronic hepatitis B functional cure.
    Lim SG, Baumert TF, Boni C, Gane E, Levrero M, Lok AS, Maini MK, Terrault NA, Zoulim F| | PubMed
  64. Quantifying the Negative Impact of Fast-food Consumption on Liver Steatosis Among United States Adults With Diabetes and Obesity.
    Kardashian A, Dodge JL, Terrault NA| | PubMed
  65. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial.
    Medeiros RP, Terrault NA, Mazo DF, Oliveira CP, Dodge J, Zitelli PM, Lopes MH, Carrilho FJ, Pessoa MG| | PubMed
  66. Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.
    Terrault NA, Lok AS, Wahed AS, Ghany MG, Perrillo RP, Fried MW, Wong DK, Khalili M, Lau DTY, Sterling RK, Di Bisceglie AM, Lisker-Melman M, Cooper SL, Chung RT, Patel K, Roberts LR, Belle SH, Janssen HLA, Hepatitis B Research Network| | PubMed
  67. Liver transplant for alcohol-associated liver disease continues to rise 2 years into the COVID-19 pandemic especially among young adults.
    Lee BP, Dodge JL, Terrault NA| | PubMed
  68. Prospective clinical trials and novel therapies in the medical management of severe alcohol-associated hepatitis.
    Pimienta M, Tien C, Terrault NA| | PubMed
  69. Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease.
    Ayyala D, Bottyan T, Tien C, Pimienta M, Yoo J, Stager K, Gonzalez JL, Stolz A, Dodge JL, Terrault NA, Han H| | PubMed
  70. Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a U.S. population-based study.
    Kardashian A, Dodge JL, Terrault NA| | PubMed
  71. Reply.
    Williamson C, Terrault N| | PubMed
  72. Health disparities in chronic liver disease.
    Kardashian A, Serper M, Terrault N, Nephew LD| | PubMed
  73. In Memoriam-Hugo R. Rosen.
    Terrault N, Shah VH, Heller T| | PubMed
  74. Geographic Density of Gastroenterologists Is Associated With Decreased Mortality From Alcohol-Associated Liver Disease.
    Lee BP, Dodge JL, Terrault NA| | PubMed
  75. Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection.
    Feld JJ, King WC, Ghany MG, Chang KM, Terrault N, Perrillo RP, Khalili M, Hinerman AS, Janssen H, Lok AS, Hepatitis B Research Network (HBRN)| | PubMed
  76. Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance.
    King WC, Sterling RK, Hinerman AS, Lok ASF, Cloherty GA, Ghany MG, HBRN HBV NOVELASSAYS GROUP| | PubMed
  77. Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion.
    Papatheodoridis GV, Lekakis V, Voulgaris T, Lampertico P, Berg T, Chan HLY, Kao JH, Terrault N, Lok AS, Reddy KR| | PubMed
  78. Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation.
    Weinberg EM, Dukewich M, Jakhete N, Stonesifer E, Im GY, Lucey MR, Shetty K, Rice JP, Victor DW, Ghobrial MR, Shetty A, Rutledge SM, Florman SS, Hsu C, Shoreibah M, Aryan M, Orandi BJ, Han H, Terrault N, Lee BP| | PubMed
  79. Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply.
    Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R| | PubMed
  80. Breakthroughs in hepatology.
    Terrault NA, Dufour JF, Schwabe RF, Wong VW| | PubMed
  81. Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission.
    Kushner T, Djerboua M, Biondi MJ, Feld JJ, Terrault N, Flemming JA| | PubMed
  82. Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy.
    Lee BP, Terrault NA| | PubMed
  83. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.
    Wang AE, Hsieh E, Turner BJ, Terrault N| | PubMed
  84. Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis.
    Lee BP, Roth N, Rao P, Im GY, Vogel AS, Hasbun J, Roth Y, Shenoy A, Arvelakis A, Ford L, Dawe I, Schiano TD, Davis JP, Rice JP, Eswaran S, Weinberg E, Han H, Hsu C, Fix OK, Maddur H, Ghobrial RM, Therapondos G, Dilkina B, Terrault NA| | PubMed
  85. Transplantation, HIV Serostatus, and Registry Data: Room for Improvement.
    Campos-Varela I, Price JC, Dodge JL, Terrault NA| | PubMed
  86. Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.
    Woreta TA, Van Natta ML, Lazo M, Krishnan A, Neuschwander-Tetri BA, Loomba R, Mae Diehl A, Abdelmalek MF, Chalasani N, Gawrieh S, Dasarathy S, Vuppalanchi R, Siddiqui MS, Kowdley KV, McCullough A, Terrault NA, Behling C, Kleiner DE, Fishbein M, Hertel P, Wilson LA, Mitchell EP, Miriel LA, Clark JM, Tonascia J, Sanyal AJ, NASH Clinical Research Network| | PubMed
  87. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD).
    Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R, Members of the Nonalcoholic Steatohepatitis Clinical Research Network| | PubMed
  88. Pregnancy-Associated Liver Diseases.
    Terrault NA, Williamson C| | PubMed
  89. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Yuan L, Hanlon CL, Terrault N, Alqahtani S, Tamim H, Lai M, Saberi B| | PubMed
  90. Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort.
    Terrault NA, Wahed AS, Feld JJ, Cooper SL, Ghany MG, Lisker-Melman M, Perrillo R, Sterling RK, Khalili M, Chung RT, Rosenthal P, Fontana RJ, Sarowar A, Lau DTY, Wang J, Lok AS, Janssen HLA| | PubMed
  91. Discordance in categorization of acute-on-chronic liver failure in the United Network for Organ Sharing database.
    Lee BP, Cullaro G, Vosooghi A, Yao F, Panchal S, Goldberg DS, Terrault NA, Mahmud N| | PubMed
  92. Reply.
    Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK| | PubMed
  93. Food Insecurity is Associated With Mortality Among U.S. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis.
    Kardashian A, Dodge JL, Terrault NA| | PubMed
  94. Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B.
    Choi HSJ, Tonthat A, Janssen HLA, Terrault NA| | PubMed
  95. Medicaid expansion and variability in mortality in the USA: a national, observational cohort study.
    Lee BP, Dodge JL, Terrault NA| | PubMed
  96. Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.
    Singal AK, Kwo P, Kwong A, Liangpunsakul S, Louvet A, Mandrekar P, McClain C, Mellinger J, Szabo G, Terrault N, Thursz M, Winder GS, Kim WR, Shah VH| | PubMed
  97. Hepatic macrosteatosis in the US pediatric deceased liver donor population.
    Purvis JW, Orandi BJ, Dhall D, McLeod C, Gutierrez Sanchez LH, Gray M, Frey K, Sheikh SS, Cannon RM, Terrault NA, Lewis CE, Locke JE| | PubMed
  98. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
    Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK| | PubMed
  99. Diverging Incidence Trends for Hepatocellular Carcinoma in Rural and Urban Settings in the United States.
    Zhou K, Gainey CS, Dodge JL, Setiawan VW, Liu L, Cockburn MG, Terrault NA| | PubMed
  100. NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040.
    Flemming JA, Djerboua M, Groome PA, Booth CM, Terrault NA| | PubMed
  101. Changes and mediators of survival disparity among Black liver transplant recipients in the United States.
    Lee BP, Dodge JL, Terrault NA| | PubMed
  102. Use of Hepatitis B Virus-Positive Organs in Organ Transplantation.
    Khemichian S, Kahn J, Terrault NA| | PubMed
  103. Enhanced Screening for Hepatitis D in the USA: Overcoming the Delta Blues.
    Terrault NA, Ghany MG| | PubMed
  104. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus.
    Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC| | PubMed
  105. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation.
    Burra P, Samuel D, Sundaram V, Duvoux C, Petrowsky H, Terrault N, Jalan R| | PubMed
  106. Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
    Zhou K, Dodge JL, Yuan L, Terrault NA| | PubMed
  107. Reply to 'Evidence against in utero transmission of hepatitis B virus'.
    Terrault NA, Cheung KW, Levy MT, Jourdain G| | PubMed
  108. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
    Lok AS, Perrillo R, Lalama CM, Fried MW, Belle SH, Ghany MG, Khalili M, Fontana RJ, Sterling RK, Terrault N, Feld JJ, Di Bisceglie AM, Lau DTY, Hassan M, Janssen HLA, Hepatitis B Research Network (HBRN)| | PubMed
  109. Hepatitis E Infection in a Longitudinal Cohort of Hepatitis C Virus and HCV/HIV Coinfected Persons.
    Sherman KE, Kottilil S, Rouster SD, Abdel-Hameed EA, Boyce CL, Meeds HL, Terrault N, Shata MT| | PubMed
  110. Sleeve gastrectomy prior to liver transplantation is superior to medical weight loss in reducing posttransplant metabolic complications.
    Sharpton SR, Terrault NA, Tavakol MM, Posselt AM| | PubMed
  111. Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.
    Traum D, Wang YJ, Schwarz KB, Schug J, Wong DK, Janssen H, Terrault NA, Khalili M, Wahed AS, Murray KF, Rosenthal P, Ling SC, Rodriguez-Baez N, Sterling RK, Lau DT, Block TM, Feldman MD, Furth EE, Lee WM, Kleiner DE, Lok AS, Kaestner KH, Chang KM| | PubMed
  112. Transplanting Kidneys From Donors With Chronic Hepatitis B: Bringing Transmission Risk Closer to Zero.
    Terrault NA| | PubMed
  113. Retail Alcohol and Tobacco Sales During COVID-19.
    Lee BP, Dodge JL, Leventhal A, Terrault NA| | PubMed
  114. Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.
    Lee BP, Dodge JL, Terrault NA| | PubMed
  115. Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action.
    Kardashian A, Wilder J, Terrault NA, Price JC| | PubMed
  116. The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder.
    Pimienta M, Dodge J, Terrault NA| | PubMed
  117. Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors.
    Terrault NA, Burton J, Ghobrial M, Verna E, Bayer J, Klein C, Victor D, Mohan S, Trotter J, Dodge J, Niemann CU, Rubin RA| | PubMed
  118. Adherence to pregnancy hepatitis B care guidelines in women and infants in the United States and evaluation of two interventions to improve care: A multicentre hospital-based study.
    Kushner T, Kaplowitz E, Mei R, Xu C, Acker A, Rosenbluth E, Oredein I, Sarkar M, Terrault N, Bansal M, Forde KA| | PubMed
  119. Caesarean section or non-breastfeeding for prevention of MTCT-beware of sending the wrong message.
    Levy MT, Terrault NA| | PubMed
  120. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.
    Sarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP, Afshar Y, Terrault NA| | PubMed
  121. Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
    Peters MG, Kottilil S, Terrault N, Amara D, Husson J, Huprikar S, Florman S, Sulkowski MS, Durand CM, Luetkemeyer AF, Rogers R, Grab J, Haydel B, Blumberg E, Dove L, Emond J, Olthoff K, Smith C, Fishbein T, Masur H, Stock PG| | PubMed
  122. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA, Kuo YF, Asrani S, Wong RJ, Ahmed A, Kwo P, Terrault N, Kamath PS, Jalan R, Singal AK| | PubMed
  123. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis.
    Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, Rinella M, Schiano TD, Lucey MR, Terrault N| | PubMed
  124. Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma.
    Zhou K, Pickering TA, Gainey CS, Cockburn M, Stern MC, Liu L, Unger JB, El-Khoueiry AB, Terrault NA| | PubMed
  125. Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation.
    Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, Garcia-Tsao G, Terrault N, Lok AS, Chung RT, Reddy KR| | PubMed
  126. Viral hepatitis and pregnancy.
    Terrault NA, Levy MT, Cheung KW, Jourdain G| | PubMed
  127. Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH.
    Loomba R, Neuschwander-Tetri BA, Sanyal A, Chalasani N, Diehl AM, Terrault N, Kowdley K, Dasarathy S, Kleiner D, Behling C, Lavine J, Van Natta M, Middleton M, Tonascia J, Sirlin C, NASH Clinical Research Network| | PubMed
  128. Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States.
    Campos-Varela I, Dodge JL, Berenguer M, Adam R, Samuel D, Di Benedetto F, Karam V, Belli LS, Duvoux C, Terrault NA| | PubMed
  129. Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD.
    Sarkar MA, Suzuki A, Abdelmalek MF, Yates KP, Wilson LA, Bass NM, Gill R, Cedars M, Terrault N, NASH Clinical Research Network| | PubMed
  130. The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study.
    Gorgen A, Galvin Z, Huang AC, Vinaixa C, O'Rourke JM, Francoz C, Hansen BE, Durand F, Elsharkawy AM, Shah T, Berenguer M, Rubin A, Calatayud D, Mehta N, Terrault NA, Lilly LB, Selzner N, Sapisochin G| | PubMed
  131. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease.
    Khemichian S, Terrault NA| | PubMed
  132. Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population.
    Wang J, Wu AH, Stanczyk FZ, Porcel J, Noureddin M, Terrault NA, Wilkens LR, Setiawan VW| | PubMed
  133. Outcomes of Pregnant Women With Cirrhosis and Their Infants in a Population-Based Study.
    Flemming JA, Mullin M, Lu J, Sarkar MA, Djerboua M, Velez MP, Brogly S, Terrault NA| | PubMed
  134. Letter to the Editor: Safety First: Favoring Prophylactic/Preemptive Over Delayed Treatment in D+/R- Transplants.
    Terrault NA, Feld JJ| | PubMed
  135. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
    Hwang JP, Feld JJ, Hammond SP, Wang SH, Alston-Johnson DE, Cryer DR, Hershman DL, Loehrer AP, Sabichi AL, Symington BE, Terrault N, Wong ML, Somerfield MR, Artz AS| | PubMed
  136. Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States.
    Kushner T, Chen Z, Tressler S, Kaufman H, Feinberg J, Terrault NA| | PubMed
  137. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.
    Sarkar M, Grab J, Dodge JL, Gunderson EP, Rubin J, Irani RA, Cedars M, Terrault N| | PubMed
  138. Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B.
    Lisker-Melman M, Khalili M, Belle SH, Terrault NA, Lin HS, Smith CI, Chung RT, Tsai N, Bzowej NH, Tran TT, Schwarzenberg SJ, Hepatitis B Research Network (HBRN)| | PubMed
  139. Mortality in adults with chronic hepatitis B infection in the United States: a population-based study.
    Zhou K, Dodge JL, Grab J, Poltavskiy E, Terrault NA| | PubMed
  140. Hepatitis C Screening Rates and Care Cascade in a Large US Insured Population, 2010-2016: Gaps to Elimination.
    Tran JN, Wong RJ, Lee JS, Bancroft T, Buikema AR, Ting J, Terrault N| | PubMed
  141. Medicaid Policy and Liver Transplant for Alcohol-Associated Liver Disease.
    Lee BP, Vittinghoff E, Pletcher MJ, Dodge JL, Terrault NA| | PubMed
  142. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
    Roth D, Bloom RD, Molnar MZ, Reese PP, Sawinski D, Sise ME, Terrault NA| | PubMed
  143. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
    Verna EC, Morelli G, Terrault NA, Lok AS, Lim JK, Di Bisceglie AM, Zeuzem S, Landis CS, Kwo P, Hassan M, Manns MP, Vainorius M, Akushevich L, Nelson DR, Fried MW, Reddy KR| | PubMed
  144. Oncogenic HBV variants and integration are present in hepatic and lymphoid cells derived from chronic HBV patients.
    Lau KC, Joshi SS, Gao S, Giles E, Swidinsky K, van Marle G, Bathe OF, Urbanski SJ, Terrault NA, Burak KW, Osiowy C, Coffin CS| | PubMed
  145. Selective use of liver transplantation for severe alcohol-associated hepatitis.
    Ayyala-Somayajula D, Han H, Terrault NA| | PubMed
  146. Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation.
    Burton JR, Terrault NA, Goldberg DS, Bloom RD, Gilroy R, Heimbach JK, Brown RS, Everson GT, Rubin E, Wiesner R, Pomfret EA| | PubMed
  147. Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America.
    Brahmania M, Liu S, Wahed AS, Yim C, Hansen BE, Khalili M, Terrault NA, Lok AS, Ghany M, Wang J, Wong D, Janssen HLA, Hepatitis B Research Network| | PubMed
  148. Liver transplantation as therapy for hepatocellular carcinoma.
    Kim B, Kahn J, Terrault NA| | PubMed
  149. Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies.
    Poordad F, Terrault NA, Alkhouri N, Tian W, Allen LF, Rabinovitz M| | PubMed
  150. Liver Transplantation in Unauthorized Immigrants in the United States.
    Lee BP, Terrault NA| | PubMed
  151. Expanding the use of hepatitis C-positive donors and keeping recipient safety at the forefront.
    Terrault NA, Sher L| | PubMed
  152. Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis.
    Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, DiMartini A, Gonzalez S, Im G, Martin P, Mathurin P, Mellinger J, Rice JP, Shah VH, Terrault N, Wall A, Winder S, Klintmalm G| | PubMed
  153. Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men.
    Sarkar M, Yates K, Suzuki A, Lavine J, Gill R, Ziegler T, Terrault N, Dhindsa S| | PubMed
  154. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.
    Cornberg M, Lok AS, Terrault NA, Zoulim F, 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty| | PubMed
  155. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡.
    Cornberg M, Lok AS, Terrault NA, Zoulim F, 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty| | PubMed
  156. Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis.
    Sarkar M, Terrault N, Chan W, Cedars MI, Huddleston HG, Duwaerts CC, Balitzer D, Gill RM| | PubMed
  157. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.
    Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA| | PubMed
  158. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.
    Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, Ahmed RL, Anadkat MJ, Arcasoy SM, Berg D, Bibee KP, Billingsley E, Black WH, Blalock TW, Bleicher M, Brennan DC, Brodland DG, Brown MR, Carroll BT, Carucci JA, Chang TW, Chaux G, Cusack CA, Dilling DF, Doyle A, Emtiazjoo AM, Ferguson NH, Fosko SW, Fox MC, Goral S, Gray AL, Griffin JR, Hachem RR, Hall SA, Hanlon AM, Hayes D, Hickey GW, Holtz J, Hopkins RS, Hu J, Huang CC, Brian Jiang SI, Kapnadak SG, Kraus ES, Lease ED, Leca N, Lee JC, Leitenberger JJ, Lim MA, Longo MI, Malik SM, Mallea JM, Menter A, Myers SA, Neuburg M, Nijhawan RI, Norman DJ, Otley CC, Paek SY, Parulekar AD, Patel MJ, Patel VA, Patton TJ, Pugliano-Mauro M, Ranganna K, Ravichandran AK, Redenius R, Roll GR, Samie FH, Shin T, Singer JP, Singh P, Soon SL, Soriano T, Squires R, Stasko T, Stein JA, Taler SJ, Terrault NA, Thomas CP, Tokman S, Tomic R, Twigg AR, Wigger MA, Zeitouni NC, Arron ST| | PubMed
  159. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.
    Kleiner DE, Brunt EM, Wilson LA, Behling C, Guy C, Contos M, Cummings O, Yeh M, Gill R, Chalasani N, Neuschwander-Tetri BA, Diehl AM, Dasarathy S, Terrault N, Kowdley K, Loomba R, Belt P, Tonascia J, Lavine JE, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network| | PubMed
  160. An Evaluation of Hepatitis C Virus Telehealth Services Serving Tribal Communities: Patterns of Usage, Evolving Needs, and Barriers.
    Stephens D, Leston J, Terrault NA, Gailloux K, Mera J, Essex W, Reilley B| | PubMed
  161. Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis.
    Radhakrishnan K, Di Bisceglie AM, Reddy KR, Lim JK, Levitsky J, Hassan MA, Darling JM, Feld JJ, Akushevich L, Vainorius M, Nelson DR, Fried MW, Brown RS, Terrault NA| | PubMed
  162. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
    Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, Chung R, Tsai N, Terrault N, Hepatitis B Research Network (HBRN)| | PubMed
  163. Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation.
    Giard JM, Dodge JL, Terrault NA| | PubMed
  164. Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study.
    Zhou K, Terrault NA| | PubMed
  165. Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality.
    Brandman D, Terrault NA| | PubMed
  166. Outcomes of liver transplantation for acute fatty liver disease of pregnancy.
    Kushner T, Tholey D, Dodge J, Saberi B, Schiano T, Terrault N| | PubMed
  167. Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.
    Di Bisceglie AM, King WC, Lisker-Melman M, Khalili M, Belle SH, Feld JJ, Ghany MG, Janssen HLA, Lau D, Lee WM, Ling SC, Cooper S, Rosenthal P, Schwarz KB, Sterling RK, Teckman JH, Terrault N, Hepatitis B Research Network (HBRN)| | PubMed
  168. Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Sarkar M, VanWagner LB, Terry JG, Carr JJ, Rinella M, Schreiner PJ, Lewis CE, Terrault N, Coronary Artery Risk Development in Young Adults (CARDIA) Cohort| | PubMed
  169. Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B.
    Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF, Hepatitis B Research Network (HBRN)| | PubMed
  170. Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.
    Lee BP, Samur S, Dalgic OO, Bethea ED, Lucey MR, Weinberg E, Hsu C, Rinella ME, Im GY, Fix OK, Therapondos G, Han H, Victor DW, Voigt MD, Eswaran S, Terrault NA, Chhatwal J| | PubMed
  171. Novel NS5B Resistance-Associated Substitution Emerges Under Failing Sofosbuvir/Ledipasvir Therapy.
    Catalli L, Martens SK, Terrault NA, Reeves JD| | PubMed
  172. Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant Database.
    Lee BP, Im GY, Rice JP, Weinberg E, Hsu C, Fix OK, Therapondos G, Han H, Victor DW, Eswaran S, Maddur H, Terrault NA| | PubMed
  173. Liver-related mortality in the United States: hepatitis C declines, non-alcoholic fatty liver and alcohol rise.
    Lee BP, Terrault NA| | PubMed
  174. Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.
    Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS, Hepatitis B Research Network| | PubMed
  175. Outcomes of Sleeve Gastrectomy in Obese Liver Transplant Candidates.
    Sharpton SR, Terrault NA, Posselt AM| | PubMed
  176. Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.
    Lee BP, Vittinghoff E, Hsu C, Han H, Therapondos G, Fix OK, Victor DW, Dronamraju D, Im GY, Voigt MD, Rice JP, Lucey MR, Eswaran S, Chen PH, Li Z, Maddur H, Terrault NA| | PubMed
  177. National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States.
    Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA| | PubMed
  178. Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis.
    Chalasani N, Abdelmalek MF, Loomba R, Kowdley KV, McCullough AJ, Dasarathy S, Neuschwander-Tetri BA, Terrault N, Ferguson B, Shringarpure R, Shapiro D, Sanyal AJ| | PubMed
  179. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
    Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA, Hepatitis B Research Network| | PubMed
  180. Prior Bariatric Surgery in Liver Transplant Candidates: Unforeseen Consequences?
    Sharpton SR, Terrault NA| | PubMed
  181. Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.
    Zhou K, Contag C, Whitaker E, Terrault N| | PubMed
  182. Reply.
    Terrault NA, Hassanein TI| | PubMed
  183. Hepatitis C elimination: challenges with under-diagnosis and under-treatment.
    Terrault NA| | PubMed
  184. HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition.
    Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA, Hepatitis B Research Network| | PubMed
  185. Return to Alcohol Use After Liver Transplant: Patterns and Surveillance.
    Lee BP, Terrault NA| | PubMed
  186. Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B: One of These Things Is Not Like the Other.
    Flemming JA, Terrault NA| | PubMed
  187. Use of hepatitis C viraemic organs in kidney transplantation: a need to hit the pause button?
    Kwong AJ, Terrault NA| | PubMed
  188. Viral Hepatitis and Hepatocellular Carcinoma.
    Liang TJ, Terrault N| | PubMed
  189. Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease.
    Sharpton SR, Yong GJM, Terrault NA, Lynch SV| | PubMed
  190. New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection.
    Coffin CS, Zhou K, Terrault NA| | PubMed
  191. Reply.
    Lee BP, Im GY, Lucey MR, Terrault NA| | PubMed
  192. Care of Patients Following Cure of Hepatitis C Virus Infection.
    Terrault NA| | PubMed
  193. Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women.
    Ajmera VH, Terrault NA, VanWagner LB, Sarkar M, Lewis CE, Carr JJ, Gunderson EP| | PubMed
  194. Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.
    Terrault NA| | PubMed
  195. Evaluating Women's Preferences for Hepatitis C Treatment During Pregnancy.
    Kushner T, Cohen J, Tien PC, Terrault NA| | PubMed
  196. Reply.
    Terrault NA, Brown RS, Lok AS, Wong JB, Bzowej NH, Chang KM, Hwang JP, Jonas MM, McMahon BJ| | PubMed
  197. Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis.
    Loomba R, Sanyal AJ, Kowdley KV, Terrault N, Chalasani NP, Abdelmalek MF, McCullough AJ, Shringarpure R, Ferguson B, Lee L, Chen J, Liberman A, Shapiro D, Neuschwander-Tetri BA| | PubMed
  198. Is Low Level Viremia Acceptable During Antiviral Therapy of Patients With HBV Infection and Decompensated Cirrhosis?
    Terrault N| | PubMed
  199. Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy.
    Chan C, Schiano T, Agudelo E, Paul Haydek J, Hoteit M, Laurito MP, Norvell JP, Terrault N, Verna EC, Yang A, Levitsky J| | PubMed
  200. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.
    Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB| | PubMed
  201. Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy.
    Bethea ED, Samur S, Kanwal F, Ayer T, Hur C, Roberts MS, Terrault N, Chung RT, Chhatwal J| | PubMed
  202. A changing landscape of liver transplantation: King HCV is dethroned, ALD and NAFLD take over!
    Terrault NA, Pageaux GP| | PubMed
  203. Outcomes of antiviral treatment in hepatitis C virus liver transplant patients off immunosuppression in the direct acting antivirals era: A case series.
    Campos-Varela I, Agudelo EZ, Terrault NA| | PubMed
  204. Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
    Terrault NA, Feld JJ, Lok ASF| | PubMed
  205. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
    Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T| | PubMed
  206. Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.
    Huang AC, Mehta N, Dodge JL, Yao FY, Terrault NA| | PubMed
  207. Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.
    VanWagner LB, Ning H, Allen NB, Siddique J, Carson AP, Bancks MP, Lewis CE, Carr JJ, Speliotes E, Terrault NA, Rinella ME, Vos MB, Lloyd-Jones DM| | PubMed
  208. Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.
    Chhatwal J, Samur S, Bethea ED, Ayer T, Kanwal F, Hur C, Roberts MS, Terrault N, Chung RT| | PubMed
  209. Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, Ghobrial RM, Dodge JL, Li Z, Terrault NA| | PubMed
  210. Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus.
    Lee BP, Terrault NA| | PubMed
  211. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.
    Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB| | PubMed
  212. Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.
    Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS, Hepatitis B Research Network (HBRN), Harvard Consortium| | PubMed
  213. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.
    Ajmera V, Belt P, Wilson LA, Gill RM, Loomba R, Kleiner DE, Neuschwander-Tetri BA, Terrault N, Nonalcoholic Steatohepatitis Clinical Research Network| | PubMed
  214. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
    El-Sherif O, Jiang ZG, Tapper EB, Huang KC, Zhong A, Osinusi A, Charlton M, Manns M, Afdhal NH, Mukamal K, McHutchison J, Brainard DM, Terrault N, Curry MP| | PubMed
  215. The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome.
    Sarkar M, Terrault N, Duwaerts CC, Tien P, Cedars MI, Huddleston H| | PubMed
  216. Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.
    Wang GP, Terrault N, Reeves JD, Liu L, Li E, Zhao L, Lim JK, Morelli G, Kuo A, Levitsky J, Sherman KE, Frazier LM, Ramani A, Peter J, Akuskevich L, Fried MW, Nelson DR| | PubMed
  217. Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?
    Zhou K, Terrault N| | PubMed
  218. Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis.
    Lim JK, Liapakis AM, Shiffman ML, Lok AS, Zeuzem S, Terrault NA, Park JS, Landis CS, Hassan M, Gallant J, Kuo A, Pockros PJ, Vainorius M, Akushevich L, Michael L, Fried MW, Nelson DR, Ben-Ari Z, HCV-TARGET Study Group| | PubMed
  219. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
    Campos-Varela I, Agudelo EZ, Sarkar M, Roberts JP, Terrault NA| | PubMed
  220. Prevalence and Predictors of Patient-Reported Long-term Mental and Physical Health After Donation in the Adult-to-Adult Living-Donor Liver Transplantation Cohort Study.
    Dew MA, Butt Z, Liu Q, Simpson MA, Zee J, Ladner DP, Holtzman S, Smith AR, Pomfret EA, Merion RM, Gillespie BW, Sherker AH, Fisher RA, Olthoff KM, Burton JR, Terrault NA, Fox AN, DiMartini AF| | PubMed
  221. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success.
    MĂ©ndez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, Shen H, Manos MM, Lanier LL, Ryan JC, McCune JM, Hartigan-O'Connor DJ| | PubMed
  222. Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.
    VanWagner LB, Khan SS, Ning H, Siddique J, Lewis CE, Carr JJ, Vos MB, Speliotes E, Terrault NA, Rinella ME, Lloyd-Jones DM, Allen NB| | PubMed
  223. Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.
    Saxena V, Khungar V, Verna EC, Levitsky J, Brown RS, Hassan MA, Sulkowski MS, O'Leary JG, Koraishy F, Galati JS, Kuo AA, Vainorius M, Akushevich L, Nelson DR, Fried MW, Terrault N, Reddy KR| | PubMed
  224. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA| | PubMed
  225. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault NA, Siddique J| | PubMed
  226. Management of hepatitis B in special populations.
    Zhou K, Terrault N| | PubMed
  227. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Terrault NA, McCaughan GW, Curry MP, Gane E, Fagiuoli S, Fung JYY, Agarwal K, Lilly L, Strasser SI, Brown KA, Gadano A, Kwo PY, Burra P, Samuel D, Charlton M, Pessoa MG, Berenguer M| | PubMed
  228. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Terrault NA, Berenguer M, Strasser SI, Gadano A, Lilly L, Samuel D, Kwo PY, Agarwal K, Curry MP, Fagiuoli S, Fung JYY, Gane E, Brown KA, Burra P, Charlton M, Pessoa MG, McCaughan GW| | PubMed
  229. Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.
    Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, MĂĽllhaupt B| | PubMed
  230. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Ajmera VH, Terrault NA, Harrison SA| | PubMed
  231. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Sarkar M, Wellons M, Cedars MI, VanWagner L, Gunderson EP, Ajmera V, Torchen L, Siscovick D, Carr JJ, Terry JG, Rinella M, Lewis CE, Terrault N| | PubMed
  232. Hepatitis C virus infection.
    Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, Younossi Z| | PubMed
  233. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Flemming JA, Kim WR, Brosgart CL, Terrault NA| | PubMed
  234. Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.
    Levitsky J, Verna EC, O'Leary JG, Bzowej NH, Moonka DK, Hyland RH, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault NA| | PubMed
  235. Estrategias para el tratamiento de pacientes con infecciĂłn por el virus de la hepatitis B sometidos a terapia inmunomoduladora: Âżes suficiente usar lamivudina?
    Terrault N| | PubMed
  236. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.
    Ajmera V, Perito ER, Bass NM, Terrault NA, Yates KP, Gill R, Loomba R, Diehl AM, Aouizerat BE, NASH Clinical Research Network| | PubMed
  237. Management of the patient with SVR.
    Terrault NA, Hassanein TI| | PubMed
  238. Real-World Experiences with Tenofovir Disoproxil Fumarate: Is this the "B-Ticket"?
    Terrault NA| | PubMed
  239. Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response.
    Terrault NA, Zeuzem S, Di Bisceglie AM, Lim JK, Pockros PJ, Frazier LM, Kuo A, Lok AS, Shiffman ML, Ben Ari Z, Akushevich L, Vainorius M, Sulkowski MS, Fried MW, Nelson DR, HCV-TARGET Study Group| | PubMed
  240. Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis.
    Yang JD, Abdelmalek MF, Guy CD, Gill RM, Lavine JE, Yates K, Klair J, Terrault NA, Clark JM, Unalp-Arida A, Diehl AM, Suzuki A, Nonalcoholic Steatohepatitis Clinical Research Network| | PubMed
  241. Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus.
    Campos-Varela I, Dodge JL, Stock PG, Terrault NA| | PubMed
  242. Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
    Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N| | PubMed
  243. Hepatitis B surface antigen loss: Not all that we hoped it would be.
    Nathanson MH, Terrault N| | PubMed
  244. Women with Cirrhosis: Prevalence, Natural History, and Management.
    Giard JM, Terrault NA| | PubMed
  245. Treatment of chronic hepatitis C in patients with cirrhosis.
    Chen T, Terrault N| | PubMed
  246. Perspectives on treating hepatitis C infection in the liver transplantation setting.
    Chen T, Terrault NA| | PubMed
  247. Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016.
    Soriano V, Young B, Terrault N| | PubMed
  248. Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation.
    Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge J, Roberts JP, Terrault NA, Feng S| | PubMed
  249. The changing 'face' of wait-listed patients in the USA.
    Terrault NA| | PubMed
  250. Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.
    Saxena V, Koraishy FM, Sise ME, Lim JK, Schmidt M, Chung RT, Liapakis A, Nelson DR, Fried MW, Terrault NA, HCV-TARGET| | PubMed
  251. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease.
    Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA| | PubMed
  252. Emerging Therapies for Nonalcoholic Fatty Liver Disease.
    Hameed B, Terrault N| | PubMed
  253. Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.
    Brown RS, O'Leary JG, Reddy KR, Kuo A, Morelli GJ, Burton JR, Stravitz RT, Durand C, Di Bisceglie AM, Kwo P, Frenette CT, Stewart TG, Nelson DR, Fried MW, Terrault NA, Hepatitis C Therapeutic Registry Research Network Study Group| | PubMed
  254. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
    Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM, Hepatitis B Research Network| | PubMed
  255. AASLD guidelines for treatment of chronic hepatitis B.
    Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH, American Association for the Study of Liver Diseases| | PubMed
  256. Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.
    Zoulim F, Liang TJ, Gerbes AL, Aghemo A, Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK, Terrault NA, Wiktor S| | PubMed
  257. Diabetes and prediabetes in patients with hepatitis B residing in North America.
    Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS, HBRN| | PubMed
  258. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.
    Lanini S, Nanni Costa A, Grossi PA, Procaccio F, Ricci A, Capobianchi MR, Terrault NA, Ippolito G| | PubMed
  259. Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.
    Flemming JA, Saxena V, Shen H, Terrault NA, Rongey C| | PubMed
  260. New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo.
    Terrault N, Monto A, Stinchon MR, Rusie E, Moreo K| | PubMed
  261. Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.
    Verna EC, Saxena V, Burton JR, O'Leary JG, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault NA, CRUSH-C Consortium| | PubMed
  262. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW| | PubMed
  263. Optimizing the pre-referral workup for gastroenterology and hepatology specialty care: consensus using the Delphi method.
    Ho CK, Boscardin CK, Gleason N, Collado D, Terdiman J, Terrault NA, Gonzales R| | PubMed
  264. Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis.
    Saxena V, Nyberg L, Pauly M, Dasgupta A, Nyberg A, Piasecki B, Winston B, Redd J, Ready J, Terrault NA| | PubMed
  265. Current Management of Hepatitis C Virus: Regimens for Peri-Liver Transplant Patients.
    Saxena V, Terrault N| | PubMed
  266. Severe Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival.
    Giard JM, Terrault NA| | PubMed
  267. Difficult-to-cure populations with chronic hepatitis C: Vanishing in the direct-acting antiviral era?
    Terrault N| | PubMed
  268. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
    Charlton M, Everson GT, Flamm SL, Kumar P, Landis C, Brown RS, Fried MW, Terrault NA, O'Leary JG, Vargas HE, Kuo A, Schiff E, Sulkowski MS, Gilroy R, Watt KD, Brown K, Kwo P, Pungpapong S, Korenblat KM, Muir AJ, Teperman L, Fontana RJ, Denning J, Arterburn S, Dvory-Sobol H, Brandt-Sarif T, Pang PS, McHutchison JG, Reddy KR, Afdhal N, SOLAR-1 Investigators| | PubMed
  269. Hepatitis C direct antiviral drugs and hepatic decompensation in patients with advanced cirrhosis: culprit or innocent bystander?
    Saxena V, Terrault NA| | PubMed
  270. Hepatitis C genotype influences post-liver transplant outcomes.
    Campos-Varela I, Lai JC, Verna EC, O'Leary JG, Todd Stravitz R, Forman LM, Trotter JF, Brown RS, Terrault NA, Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C)| | PubMed
  271. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
    Price JC, Terrault NA| | PubMed
  272. Management strategies for hepatitis B-infected patients undergoing immunomodulatory therapy: Is lamivudine enough?
    Terrault N| | PubMed
  273. Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction.
    Lai JC, Bikle DD, Lizaola B, Hayssen H, Terrault NA, Schwartz JB| | PubMed
  274. Human immunodeficiency virus and liver transplantation: Hepatitis C is the last hurdle.
    Stock PG, Terrault NA| | PubMed
  275. High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency Departments.
    Ho CK, Maselli JH, Terrault NA, Gonzales R| | PubMed
  276. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.
    Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge JL, Roberts JP, Terrault NA, Feng S| | PubMed
  277. Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?
    Di Bisceglie AM, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH| | PubMed
  278. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients.
    Campos-Varela I, Straley S, Agudelo EZ, Carlson L, Terrault NA| | PubMed
  279. Reply: To PMID 25045002.
    Goel A, Terrault N| | PubMed
  280. Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C.
    Lai JC, Shoback DM, Zipperstein J, Lizaola B, Tseng S, Terrault NA| | PubMed
  281. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective.
    Price JC, Terrault NA| | PubMed
  282. Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?
    Flemming JA, Kim WR, Terrault NA| | PubMed
  283. Outcomes in liver transplantation: does sex matter?
    Sarkar M, Watt KD, Terrault N, Berenguer M| | PubMed
  284. Disparate detection outcomes for anti-HCV IgG and HCV RNA in dried blood spots.
    Tejada-Strop A, Drobeniuc J, Mixson-Hayden T, Forbi JC, Le NT, Li L, Mei J, Terrault N, Kamili S| | PubMed
  285. An interferon-free antiviral regimen for HCV after liver transplantation.
    Kwo PY, Mantry PS, Coakley E, Te HS, Vargas HE, Brown R, Gordon F, Levitsky J, Terrault NA, Burton JR, Xie W, Setze C, Badri P, Pilot-Matias T, Vilchez RA, Forns X| | PubMed
  286. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
    Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, McCullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E, NASH Clinical Research Network| | PubMed
  287. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update.
    Miro JM, Stock P, Teicher E, Duclos-Vallée JC, Terrault N, Rimola A| | PubMed
  288. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
    Charlton M, Gane E, Manns MP, Brown RS, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Samuel D, Forns X, Terrault NA| | PubMed
  289. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
    Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N| | PubMed
  290. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N| | PubMed
  291. Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.
    Campos-Varela I, Peters MG, Terrault NA| | PubMed
  292. Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.
    Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA| | PubMed
  293. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.
    Flemming JA, Yang JD, Vittinghoff E, Kim WR, Terrault NA| | PubMed
  294. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure.
    Terrault NA, Hassanein T, Howell CD, Joshi S, Lake J, Sher L, Vargas H, McIntosh J, Tang S, Jenkins TM| | PubMed
  295. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.
    Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS, Hepatitis B Research Network, Hepatitis B Research Network| | PubMed
  296. Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals - authors' reply.
    Saxena V, Monto A, Terrault N| | PubMed
  297. Ending vertical transmission of hepatitis B: the third trimester intervention.
    Sarkar M, Terrault NA| | PubMed
  298. A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.
    Burton JR, O'Leary JG, Verna EC, Saxena V, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault NA| | PubMed
  299. Characteristics and management of patients with chronic hepatitis B in an integrated care setting.
    Sarkar M, Shvachko VA, Ready JB, Pauly MP, Terrault NA, Peters MG, Manos MM| | PubMed
  300. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
    Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R, A2ALL Study Group| | PubMed
  301. Sexual transmission of hepatitis C: A rare event among heterosexual couples.
    Dodge JL, Terrault NA| | PubMed
  302. Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection.
    Hartigan-O'Connor DJ, Lin D, Ryan JC, Shvachko VA, Cozen ML, Segal MR, Terrault NA, Lanier LL, Manos MM, McCune JM| | PubMed
  303. Solid organ transplants in HIV-infected patients.
    Harbell J, Terrault NA, Stock P| | PubMed
  304. Donor Risk Index for African American liver transplant recipients with hepatitis C virus.
    Shores NJ, Dodge JL, Feng S, Terrault NA| | PubMed
  305. Reply: To PMID 23175457.
    Terrault N, Dodge J, Alter M| | PubMed
  306. Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study.
    Freeman J, Emond J, Gillespie BW, Appelbaum PS, Weinrieb R, Hill-Callahan P, Gordon EJ, Terrault N, Trotter J, Ashworth A, Dew MA, Pruett T, A2ALL Study Group| | PubMed
  307. Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naĂŻve patients with hepatitis C virus genotype 1 infection.
    Marcellin P, Cooper C, Balart L, Larrey D, Box T, Yoshida E, Lawitz E, Buggisch P, Ferenci P, Weltman M, Labriola-Tompkins E, Le Pogam S, Nájera I, Thomas D, Hooper G, Shulman NS, Zhang Y, Navarro MT, Lim CY, Brunda M, Terrault NA, Yetzer ES| | PubMed
  308. Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era?
    Terrault N| | PubMed
  309. Reply: To PMID 23281277.
    Lucey MR, Terrault N| | PubMed
  310. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study.
    Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, Gish RG, Busch MP, Reingold AL, Alter MJ| | PubMed
  311. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation.
    Everson GT, Terrault NA, Lok AS, Rodrigo del R, Brown RS, Saab S, Shiffman ML, Al-Osaimi AM, Kulik LM, Gillespie BW, Everhart JE, Adult-to-Adult Living Donor Liver Transplantation Cohort Study| | PubMed
  312. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.
    Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, Teperman LW| | PubMed
  313. Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection.
    Flemming JA, Terrault NA| | PubMed
  314. Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.
    Biggins SW, Bambha KM, Terrault NA, Inadomi J, Shiboski S, Dodge JL, Gralla J, Rosen HR, Roberts JP| | PubMed
  315. Acute hepatitis C in an HIV-infected patient: a case report and review of literature.
    Driver TH, Terrault N, Saxena V| | PubMed
  316. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.
    Gordon SC, Pockros PJ, Terrault NA, Hoop RS, Buikema A, Nerenz D, Hamzeh FM| | PubMed
  317. Hepatitis C virus: a critical appraisal of new approaches to therapy.
    Nelson DR, Jensen DM, Sulkowski MS, Everson G, Fried MW, Gordon SC, Jacobson I, Reau NS, Sherman K, Terrault N, Thomas D| | PubMed
  318. Liver transplantation in the setting of chronic HCV.
    Terrault N| | PubMed
  319. Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies.
    Saxena V, Terrault N| | PubMed
  320. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
    Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG, Solid Organ Transplantation in HIV: Multi-Site Study Investigators| | PubMed
  321. Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.
    Saxena V, Lai JC, O'Leary JG, Verna EC, Brown RS, Stravitz RT, Trotter JF, Krishnan K, Terrault NA, Consortium to Study Health Outcomes in HCV Liver Transplant Recipients| | PubMed
  322. Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.
    Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS, Stravitz RT, Duman JD, Forman LM, Terrault NA, Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C)| | PubMed
  323. Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.
    Verna EC, Valadao R, Farrand E, Pichardo EM, Lai JC, Terrault NA, Brown RS| | PubMed
  324. The option of HBIG-free prophylaxis against recurrent HBV.
    Fox AN, Terrault NA| | PubMed
  325. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
    Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA| | PubMed
  326. Multidisciplinary management of hepatocellular carcinoma.
    Guy J, Kelley RK, Roberts J, Kerlan R, Yao F, Terrault N| | PubMed
  327. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE| | PubMed
  328. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.
    Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA| | PubMed
  329. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.
    Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA| | PubMed
  330. Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.
    Lai JC, Verna EC, Brown RS, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault NA, Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C)| | PubMed
  331. Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis.
    Bacchetti P, Boylan R, Astemborski J, Shen H, Mehta SH, Thomas DL, Terrault NA, Monto A| | PubMed
  332. PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.
    Bzowej N, Nelson DR, Terrault NA, Everson GT, Teng LL, Prabhakar A, Charlton MR, PHOENIX Study Group| | PubMed
  333. Individualizing hepatitis B infection prophylaxis in liver transplant recipients.
    Fox AN, Terrault NA| | PubMed
  334. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study.
    Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE, Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group| | PubMed
  335. Management of posttransplant hepatitis C infection.
    Aytaman A, Kaufman M, Terrault NA| | PubMed
  336. Viral hepatitis and inflammatory bowel disease.
    Hou JK, Velayos F, Terrault N, Mahadevan U| | PubMed
  337. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
    Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, Carrington M| | PubMed
  338. Telaprevir for previously treated chronic HCV infection.
    McHutchison JG, Manns MP, Muir AJ, Terrault NA, Jacobson IM, Afdhal NH, Heathcote EJ, Zeuzem S, Reesink HW, Garg J, Bsharat M, George S, Kauffman RS, Adda N, Di Bisceglie AM, PROVE3 Study Team| | PubMed
  339. The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance.
    Sofair AN, Barry V, Manos MM, Thomas A, Zaman A, Terrault NA, Murphy RC, Stabach N, Huie S, Van Ness G, Bell BP, Bialek S| | PubMed
  340. Understanding the natural history of chronic HBV and HCV infections.
    Thomas DL, Di Bisceglie AM, Alter HJ, Terrault NA| | PubMed
  341. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.
    Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, Fisher RA, Trotter JF, Brown RS, Terrault NA, Hayashi PH, Hong JC, A2ALL Study Group| | PubMed
  342. Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant.
    Bacchetti P, Boylan RD, Terrault NA, Monto A, Berenguer M| | PubMed
  343. A glimpse of future hepatitis C virus treatment paradigms.
    Terrault N, Khalili M| | PubMed
  344. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).
    Frederick T, Burian P, Terrault N, Cohen M, Augenbraun M, Young M, Seaberg E, Justman J, Levine AM, Mack WJ, Kovacs A| | PubMed
  345. Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study.
    Evon DM, Ramcharran D, Belle SH, Terrault NA, Fontana RJ, Fried MW, Virahep-C Study Group| | PubMed
  346. Prevalence and predictors of hepatic steatosis in adults with newly diagnosed chronic liver disease due to hepatitis C.
    Hayman AV, Sofair AN, Manos MM, Thomas A, Terrault N, Ness GV, Stabach N, Robert M, Rumore G, Corless C, Bell B, Bialek S, Zaman A| | PubMed
  347. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.
    Kim WR, Terrault NA, Pedersen RA, Therneau TM, Edwards E, Hindman AA, Brosgart CL| | PubMed
  348. Older donors: mounting risks for the hepatitis C-infected liver transplant recipient?
    Valadao RM, Terrault NA| | PubMed
  349. Is recurrent hepatitis C worse with living donors?
    Kuo A, Terrault NA| | PubMed
  350. Management of patients co-infected with HBV and HCV.
    Coffin CS, Terrault NA| | PubMed
  351. Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipients.
    Terrault NA, Tran TT, Schiff E, McGuire BM, Brown RS, Tupper R, Ramanathan S, Enejosa J, Zhong L, Zong J, Study 531 Team| | PubMed
  352. Benefits and risks of combination therapy for hepatitis B.
    Terrault NA| | PubMed
  353. Transplant tourism to China: the impact on domestic patient-care decisions.
    Biggins SW, Bambha K, Terrault N, Inadomi J, Roberts JP, Bass N| | PubMed
  354. Hepatitis C virus: a critical appraisal of approaches to therapy.
    Nelson DR, Davis GL, Jacobson I, Everson GT, Fried MW, Harrison SA, Hassanein T, Jensen DM, Lindsay KL, Terrault N, Zein N| | PubMed
  355. Hepatitis C therapy before and after liver transplantation.
    Terrault NA| | PubMed
  356. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
    Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA| | PubMed
  357. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
    Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP| | PubMed
  358. Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.
    Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, Hoofnagle JH, Belle SH, VIRAHEP-C Study Group| | PubMed
  359. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.
    Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, Dhotre KB, Murphy RC, Van Ness GR, Stabach N, Robert ME, Bower WA, Bialek SR, Sofair AN| | PubMed
  360. Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy.
    Burton JR, Klarquist J, Im K, Smyk-Pearson S, Golden-Mason L, Castelblanco N, Terrault N, Rosen HR, Virahep-C Study Group| | PubMed
  361. Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.
    Howell CD, Dowling TC, Paul M, Wahed AS, Terrault NA, Taylor M, Jeffers L, Hoofnagle JH, Virahep-C Study Group| | PubMed
  362. Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment.
    Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP| | PubMed
  363. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F, Loggi E, Chisholm JV, Biselli M, Morelli MC, Cursaro C, Terrault NA, Bernardi M, Bertoletti A, Andreone P, Brander C| | PubMed
  364. Are HIV-infected patients candidates for liver transplantation?
    Samuel D, Weber R, Stock P, Duclos-Vallée JC, Terrault N| | PubMed
  365. Cognitive impairment in hepatitis C patients on antiviral therapy.
    Irwin J, Terrault N| | PubMed
  366. Influence of cannabis use on severity of hepatitis C disease.
    Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA| | PubMed
  367. Management of hepatitis B in liver transplant recipients.
    Coffin CS, Terrault NA| | PubMed
  368. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation.
    Trotter JF, Wisniewski KA, Terrault NA, Everhart JE, Kinkhabwala M, Weinrieb RM, Fair JH, Fisher RA, Koffron AJ, Saab S, Merion RM, A2ALL Study Group| | PubMed
  369. Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy.
    Terrault NA, Jacobson IM| | PubMed
  370. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
    Terrault NA, Adey DB| | PubMed
  371. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
    Schiff E, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann H, Samuel D, Zeuzem S, Villeneuve JP, Arterburn S, Borroto-Esoda K, Brosgart C, Chuck S, Adefovir Dipivoxil Study 45 Intrnational Investigators Group| | PubMed
  372. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?
    Kuo A, Terrault NA| | PubMed
  373. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB, A2ALL Study Group| | PubMed
  374. The changing epidemiology and natural history of hepatitis C virus infection.
    Bialek SR, Terrault NA| | PubMed
  375. Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.
    Galun E, Terrault NA, Eren R, Zauberman A, Nussbaum O, Terkieltaub D, Zohar M, Buchnik R, Ackerman Z, Safadi R, Ashur Y, Misrachi S, Liberman Y, Rivkin L, Dagan S| | PubMed
  376. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.
    Fontana RJ, Kleiner DE, Bilonick R, Terrault N, Afdhal N, Belle SH, Jeffers LJ, Ramcharran D, Ghany MG, Hoofnagle JH, Virahep-C Study Group| | PubMed
  377. De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
    Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG| | PubMed
  378. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.
    Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD, Virahep-C Study Group| | PubMed
  379. Treating hepatitis C infection in liver transplant recipients.
    Terrault NA, Berenguer M| | PubMed
  380. Evidence-based incorporation of serum sodium concentration into MELD.
    Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G| | PubMed
  381. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation.
    Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG| | PubMed
  382. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F, HCV Meta-Analysis (on) Individual Patients' Data Study Group| | PubMed
  383. Management of recurrent hepatitis C in liver transplant recipients.
    Biggins SW, Terrault NA| | PubMed
  384. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years.
    Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA| | PubMed
  385. Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.
    Dickson RC, Terrault NA, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS, Horwith G, Brundage R, Lok A| | PubMed
  386. Treatment of recurrent hepatitis C in liver transplant recipients.
    Terrault NA| | PubMed
  387. Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy.
    Terrault NA, Pawlotsky JM, McHutchison J, Anderson F, Krajden M, Gordon S, Zitron I, Perrillo R, Gish R, Holodniy M, Friesenhahn M| | PubMed
  388. A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients.
    Davis GL, Nelson DR, Terrault N, Pruett TL, Schiano TD, Fletcher CV, Sapan CV, Riser LN, Li Y, Whitley RJ, Gnann JW, Collaborative Antiviral Study Group| | PubMed
  389. Treatment of recurrent hepatitis C after liver transplantation.
    Biggins SW, Terrault NA| | PubMed
  390. Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective.
    Terrault N, Roche B, Samuel D| | PubMed
  391. Update on chronic hepatitis C.
    Wong W, Terrault N| | PubMed
  392. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease.
    Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM, Terrault NA| | PubMed
  393. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.
    Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA| | PubMed
  394. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
    Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U| | PubMed
  395. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA| | PubMed
  396. Chronic Hepatitis B.
    Straley SD, Terrault NA| | PubMed
  397. Antiviral therapy in patients with chronic hepatitis B and cirrhosis.
    Lai CJ, Terrault NA| | PubMed
  398. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S| | PubMed
  399. Hepatitis C virus and lichen planus: a review.
    Chainani-Wu N, Lozada-Nur F, Terrault N| | PubMed
  400. Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection.
    French AL, Benning L, Anastos K, Augenbraun M, Nowicki M, Sathasivam K, Terrault NA| | PubMed
  401. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.
    Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA| | PubMed
  402. Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).
    Elbeik T, Surtihadi J, Destree M, Gorlin J, Holodniy M, Jortani SA, Kuramoto K, Ng V, Valdes R, Valsamakis A, Terrault NA| | PubMed
  403. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.
    Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP| | PubMed
  404. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.
    Schiff ER, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann HL, Samuel D, Zeuzem S, Lilly L, Rendina M, Villeneuve JP, Lama N, James C, Wulfsohn MS, Namini H, Westland C, Xiong S, Choy GS, Van Doren S, Fry J, Brosgart CL, Adefovir Dipovoxil Study 435 International Investigators Group| | PubMed
  405. Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation.
    Terrault NA| | PubMed
  406. Kidney and liver transplantation in HIV-infected patients: case presentations and review.
    Roland ME, Adey D, Carlson LL, Terrault NA| | PubMed
  407. Prevalence of HBV precore/core promoter variants in the United States.
    Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok AS, U.S. HBV Epidemiology Study Group| | PubMed
  408. Hepatitis B immune globulin preparations and use in liver transplantation.
    Terrault NA, Vyas G| | PubMed
  409. Hepatitis B virus genotypes in the United States: results of a nationwide study.
    Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok AS| | PubMed
  410. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL| | PubMed
  411. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.
    Chan KA, Truman A, Gurwitz JH, Hurley JS, Martinson B, Platt R, Everhart JE, Moseley RH, Terrault N, Ackerson L, Selby JV| | PubMed
  412. Should HCV-related cirrhosis be a contraindication for retransplantation?
    Biggins SW, Terrault NA| | PubMed
  413. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation.
    Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, Lorber MI, Maters RG, McBride MA, Metzger RA, Nolte FS, O'Connor KJ, Roth D, Terrault NA, Henry ML| | PubMed
  414. Alcohol use and hepatitis C.
    Peters MG, Terrault NA| | PubMed
  415. Sexual activity as a risk factor for hepatitis C.
    Terrault NA| | PubMed
  416. Motion - the available treatments for hepatitis C are cost effective: arguments for the motion.
    Terrault N| | PubMed
  417. Treatment of recurrent hepatitis B infection in liver transplant recipients.
    Terrault NA| | PubMed
  418. Burden of liver disease in the United States: summary of a workshop.
    Kim WR, Brown RS, Terrault NA, El-Serag H| | PubMed
  419. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
    Crippin JS, McCashland T, Terrault N, Sheiner P, Charlton MR| | PubMed
  420. Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties.
    Galun E, Eren R, Safadi R, Ashour Y, Terrault N, Keeffe EB, Matot E, Mizrachi S, Terkieltaub D, Zohar M, Lubin I, Gopher J, Shouval D, Dagan S| | PubMed
  421. Chronic Hepatitis B.
    Terrault NA| | PubMed